The bill S. 4741, titled the "Preserving Life-saving Access to Specialty Medicines in America Act" or the "PLASMA Act," proposes amendments to the Social Security Act. It seeks to implement a phase-in process for plasma-derived products under the manufacturer discount...

H.R. 10305 proposes an amendment to the Social Security Act, specifically targeting the part D manufacturer discount program under Medicare. The bill seeks to exempt certain orally administered drugs from this discount program. It specifies that these exemptions apply to...